Montelukast Bluefish (Montelukast)

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1. This prevents leukotrienes—chemicals that cause bronchoconstriction, mucus production, and airway swelling—from binding to their receptors, thereby reducing airway narrowing and inflammation.

The dose of Montelukast Bluefish is determined by the prescribing healthcare professional based on the patient’s age, weight, and specific condition. Dosage forms and strengths are selected to match the therapeutic need, and the prescriber provides individualized instructions.

Safety data for Montelukast in pregnancy are limited, and it should only be used if the potential benefit justifies any potential risk to the fetus. Montelukast is excreted in breast milk in small amounts; breastfeeding mothers should discuss risks and benefits with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids and long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑sensitive asthma or those who prefer a once‑daily oral tablet, but it may be less potent for acute symptom relief compared with inhaled bronchodilators.

Montelukast Bluefish should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Montelukast Bluefish is taken orally, usually once daily in the evening, with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks, though rare, include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, and neuropsychiatric events like suicidal thoughts or behavior. Patients should seek immediate medical attention if they experience swelling of the face or throat, rash with blistering, or significant mood changes.

Montelukast Bluefish should not be used by individuals with a known hypersensitivity to montelukast or any of its excipients. Caution is advised for patients with severe liver disease, and it is generally avoided in children under the approved age for the specific formulation.